
Mike Gallagher
4.3K posts

Mike Gallagher
@GeneticsMike7
Geneticist and stem cell biologist studying epigenetics and neurological disease @WhiteheadInst @MIT. B.S. @Muhlenberg Ph.D. @Penn



Let them practice medicine without Monday morning quarter backing from administrators, insurance companies, malpractice lawyers, the academy & the state. It’s a perfect storm for the medical profession. At the moment, doctors have all of the liability and none of the autonomy to treat patients.




NIH FY2025 funding data finally emerges on RePORT drugmonkey.wordpress.com/2026/03/06/nih… via @drugmonkeyblog




Ever wondered who the real rockstars of R01s from the past 5 years? We ranked the most funded PIs in cancer R01s from 2020–2024. Anyone with persistent effort can (maybe) win one R01. Winning 38–48 of them over 5 years is something else entirely. R01s flow towards people whose ideas repeatedly translate into durable programs. Durability means: • hypotheses that age well • biology that generalizes • institutions that trust you with long arcs • and ideas NIH is willing to underwrite repeatedly ======== Meet the rockstars, their institutions, and an examplary funded research: Allen Gao (University of California, Davis @ucdavis) 48 R01 awards | $14.6M Sample Award: 5R01CA271327 Novel therapeutics dual targeting intracrine androgen synthesis and AR for advanced prostate cancer Xiaoqi Liu (University of Kentucky @universityofky ) 46 R01 awards | $20.3M Sample Award: 5R01CA272483-03 Targeting the PLK1/PDCD4/mTORC2 signaling to treat castration-resistant prostate cancer Tim Rebbeck (Dana-Farber Cancer Institute @DanaFarber) 43 R01 awards | $10.4M Sample Award: 5R01CA259200 Genetic and genomic variation in prostate cancer Shoujiang Gao (University of Pittsburgh School of Medicine @PittTweet) 42 R01 awards | $21.3M Sample Award: 5R01CA284554 Impact of microbiota on AIDS-Kaposi’s sarcoma development and therapy James Basilion (Case Western Reserve University School of Medicine @cwru) 39 R01 awards | $18.2M Sample Award: 5R01CA255925 Highly selective targeted theranostics for prostate cancers Binghui Shen (City of Hope Beckman Research Institute @cityofhope) 39 R01 awards | $16.6M Sample Award: 5R01CA233664 DNA repair gene mutations and prostate cancer Daniela Bota (UC Irvine @UCIMedSchool) 39 R01 awards | $10.4M Sample Award: 5R01CA263806 Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous system Nan Hao (UC San Diego @UCSDMedSchool) 38 R01 awards | $17.1M Sample Award: 1R01AG086348 Engineered genetic clocks for control of cellular aging Zhenghe Wang (Case Western Reserve University School of Medicine @cwru) 38 R01 awards | $16.8M Sample Award: 4R01CA260629 Role of PTPRT in colon cancer progression and metastasis Tony Faber (Virginia Commonwealth University School of Medicine) 38 R01 awards | $16.6M Sample Award: 5R01CA276207 MYCN drives a ferroptotic vulnerability in neuroblastoma











Our multi-ancestry GWAS of EXTernalizing conditions (ADHD, substance use...) in ~4M people reveals neurodevelopmental risk, drug-repurposing targets, and yields one of the strongest psychiatric polygenic indices yet! 🧬🎉 doi.org/10.64898/2026.…


















